Johnson & Johnson Mergers & Acquisitions

Johnson & Johnson M&A Summary

Johnson & Johnson has acquired 49 companies, including 8 in the last 5 years. A total of 10 acquisitions came from private equity firms. It has also divested 18 assets.

Johnson & Johnson’s largest acquisition to date was in 2017, when it acquired Actelion for $30.0B. It’s largest disclosed sale occurred in 2014, when it sold Ortho Clinical Diagnostics Holdings to The Carlyle Group for $4.2B. Johnson & Johnson has acquired in 14 different US states, and 7 countries. The Company’s most targeted sectors include life science (43%) and medical products (37%).

M&A Summary

  • M&A Total Activity65
    • M&A Buy Activity47
    • M&A Sell Activity18
  • Total Sectors Invested 7
  • Total Countries Invested 7
  • M&A Buy/Sell Connections 25

Johnson & Johnson

Johnson & Johnson

One Johnson & Johnson Plaza,
New Brunswick, New Jersey 08933
United States,
(732) 524-0400
www.jnj.com

All (65) Buy (47) Sell (18)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2025-11-17 Halda Therapeutics · Life Science
New Haven, Connecticut · www.haldatherapeutics.com

Halda Therapeutics is a clinical-stage biotechnology company developing a novel class of cancer therapies based on its proprietary RIPTAC (Regulated Induced Proximity Targeting Chimeras) platform. The RIPTAC modality works via a “hold-and-kill” mechanism, binding a tumor-specific protein and an essential cellular protein to trigger selective cancer-cell death. Halda Therapeutics is based in New Haven, Connecticut

3,050 Add-on Acquisition

Johnson & Johnson

-

Try Mergr Free — See This and 221,292+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.